Search Results - "Chung, Hyun Cheol"

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer by Shitara, Kohei, Bang, Yung-Jue, Iwasa, Satoru, Sugimoto, Naotoshi, Ryu, Min-Hee, Sakai, Daisuke, Chung, Hyun-Cheol, Kawakami, Hisato, Yabusaki, Hiroshi, Lee, Jeeyun, Saito, Kaku, Kawaguchi, Yoshinori, Kamio, Takahiro, Kojima, Akihito, Sugihara, Masahiro, Yamaguchi, Kensei

“…Approximately 15 to 20% of gastric adenocarcinomas express HER2. Trastuzumab deruxtecan is an antibody-drug conjugate composed of trastuzumab and the…”
Get full text

Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis by Kang, Duk-Hyun, Park, Sung-Ji, Lee, Seung-Ah, Lee, Sahmin, Kim, Dae-Hee, Kim, Hyung-Kwan, Yun, Sung-Cheol, Hong, Geu-Ru, Song, Jong-Min, Chung, Cheol-Hyun, Song, Jae-Kwan, Lee, Jae-Won, Park, Seung-Woo

“…Asymptomatic patients with very severe aortic stenosis were randomly assigned to either early valve-replacement surgery or conservative care. At a median of 6…”
Get full text

Early Surgery versus Conventional Treatment for Infective Endocarditis by Kang, Duk-Hyun, Kim, Yong-Jin, Kim, Sung-Han, Sun, Byung Joo, Kim, Dae-Hee, Yun, Sung-Cheol, Song, Jong-Min, Choo, Suk Jung, Chung, Cheol-Hyun, Song, Jae-Kwan, Lee, Jae-Won, Sohn, Dae-Won

“…The timing of surgery in the context of acute endocarditis associated with valvular failure and large vegetations is controversial. In this randomized trial in…”
Get full text

Sunitinib Versus Sorafenib in Advanced Hepatocellular Cancer: Results of a Randomized Phase III Trial by CHENG, Ann-Lii, KANG, Yoon-Koo, OMATA, Masao, LOWENTHAL, Susan Pitman, LANZALONE, Silvana, LIQIANG YANG, JOSE LECHUGA, Maria, RAYMOND, Eric, LIN, Deng-Yn, PARK, Joong-Won, KUDO, Masatoshi, SHUKUI QIN, CHUNG, Hyun-Cheol, XIANGQUN SONG, JIANMINGXU, POGGI, Guido

“…Open-label, phase III trial evaluating whether sunitinib was superior or equivalent to sorafenib in hepatocellular cancer. Patients were stratified and…”
Get full text

Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial by Lordick, Florian, Prof, Kang, Yoon-Koo, Prof, Chung, Hyun-Cheol, Prof, Salman, Pamela, MD, Oh, Sang Cheul, Prof, Bodoky, György, Prof, Kurteva, Galina, MD, Volovat, Constantin, MD, Moiseyenko, Vladimir M, Prof, Gorbunova, Vera, Prof, Park, Joon Oh, MD, Sawaki, Akira, MD, Celik, Ilhan, Prof, Götte, Heiko, PhD, Melezínková, Helena, MD, Moehler, Markus, Prof

“…Summary Background Patients with advanced gastric cancer have a poor prognosis and few efficacious treatment options. We aimed to assess the addition of…”
Get full text

Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 Study by OHTSU, Atsushi, AJANI, Jaffer A, MURO, Kei, YEUL HONG KIM, FERRY, David, TEBBUTT, Niall C, AL-BATRAN, Salah-Eddin, SMITH, Heind, COSTANTINI, Chiara, RIZVI, Syed, LEBWOHL, David, VAN CUTSEM, Eric, BAI, Yu-Xian, BANG, Yung-Jue, CHUNG, Hyun-Cheol, PAN, Hong-Ming, SAHMOUD, Tarek, LIN SHEN, YEH, Kun-Huei, KEISHO CHIN

“…The oral mammalian target of rapamycin inhibitor everolimus demonstrated promising efficacy in a phase II study of pretreated advanced gastric cancer. This…”
Get full text

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial by Bang, Yung-Jue, Prof, Kim, Young-Woo, MD, Yang, Han-Kwang, Prof, Chung, Hyun Cheol, Prof, Park, Young-Kyu, Prof, Lee, Kyung Hee, Prof, Lee, Keun-Wook, Prof, Kim, Yong Ho, Prof, Noh, Sang-Ik, MD, Cho, Jae Yong, Prof, Mok, Young Jae, Prof, Kim, Yeul Hong, Prof, Ji, Jiafu, Prof, Yeh, Ta-Sen, Prof, Button, Peter, MSc, Sirzén, Florin, MD, Noh, Sung Hoon, Prof

“…Summary Background D2 gastrectomy is recommended in US and European guidelines, and is preferred in east Asia, for patients with resectable gastric cancer…”
Get full text

Prognostic role of body composition parameters in gastric/gastroesophageal junction cancer patients from the EXPAND trial by Hacker, Ulrich T., Hasenclever, Dirk, Linder, Nicolas, Stocker, Gertraud, Chung, Hyun‐Cheol, Kang, Yoon‐Koo, Moehler, Markus, Busse, Harald, Lordick, Florian

“…Background Body fat and/or muscle composition influences prognosis in several cancer types. For advanced gastric and gastroesophageal junction cancer, we…”
Get full text

Randomized Trial of Stents versus Bypass Surgery for Left Main Coronary Artery Disease by Park, Seong-Wook, Park, Duk-Woo, Park, Seung-Jung, Kim, Hyo-Soo, Kim, Won-Jang, Kim, Young-Hak, Yun, Sung-Cheol, Ahn, Jung-Min, Song, Hae Geun, Lee, Jae-Won, Lee, Seung-Whan, Lee, Sang-Gon, Lee, Cheol Whan, Lee, Jong-Young, Kang, Soo-Jin, Chung, Cheol-Hyun, Lim, Do-Sun, Rha, Seung-Woon, Gwon, Hyeon-Cheol, Chae, In-Ho, Jang, Yangsoo, Jeong, Myung-Ho, Tahk, Seung-Jea, Seung, Ki Bae

“…Patients with unprotected left main coronary artery stenosis were assigned to either CABG or PCI with sirolimus-eluting stents. At 1 year, with a wide…”
Get full text

Clinical and echocardiographic outcomes after surgery for severe isolated tricuspid regurgitation by Kim, Joon Bum, MD, Jung, Sung-Ho, MD, Choo, Suk Jung, MD, PhD, Chung, Cheol Hyun, MD, PhD, Lee, Jae Won, MD, PhD

“…Objective Few studies have investigated the outcomes after surgical correction of severe isolated tricuspid regurgitation. Methods The medical records of 51…”
Get full text

Impact of Optimal Medical Therapy on Long-Term Outcomes After Myocardial Revascularization for Multivessel Coronary Disease by Park, Jinsun, Kim, Se Hee, Kim, Mijin, Lee, Jinho, Choi, Yeonwoo, Kim, Hoyun, Kim, Tae Oh, Kang, Do-Yoon, Ahn, Jung-Min, Yoo, Jae-Suk, Kim, Ho Jin, Kim, Joon Bum, Choo, Suk Jung, Chung, Cheol-Hyun, Park, Seung-Jung, Park, Duk-Woo

“…Although optimal medical therapy (OMT) after coronary revascularization is advocated for intensive secondary prevention, its criteria and effect on long-term…”
Get full text

Ixabepilone Plus Capecitabine for Metastatic Breast Cancer Progressing After Anthracycline and Taxane Treatment by THOMAS, Eva S, GOMEZ, Henry L, BINGHE XU, CAMPONE, Mario, LERZO, Guillermo L, PECK, Ronald A, MUKHOPADHYAY, Pralay, VAHDAT, Linda T, ROCHE, Henri H, LI, Rubi K, CHUNG, Hyun-Cheol, FEIN, Luis E, CHAN, Valorie F, JASSEM, Jacek, PIVOT, Xavier B, KLIMOVSKY, Judith V, HURTADO DE MENDOZA, Fernando

“…Effective treatment options for patients with metastatic breast cancer resistant to anthracyclines and taxanes are limited. Ixabepilone has single-agent…”
Get full text

Impact of Early Surgery and Staging Classification on Survival in Asymptomatic Very Severe Aortic Stenosis by Park, Sung-Ji, Lee, Sahmin, Lee, Seung-Ah, Kim, Dae-Hee, Kim, Hyung-Kwan, Hong, Geu-Ru, Song, Jong-Min, Chung, Cheol-Hyun, Park, Seung Woo, Kang, Duk-Hyun

Get full text

Myocardial Scar and Revascularization on Mortality in Ischemic Cardiomyopathy (from the Late Gadolinium Enhancement Cardiac Magnetic Resonance Study) by Park, Hanbit, Kang, Do-Yoon, Ahn, Jung-Min, Yang, Dong Hyun, Koo, Hyun Jung, Kang, Joon-Won, Lee, Pil Hyung, Lee, Sang Eun, Kim, Min-Seok, Kang, Soo-Jin, Park, Duk-Woo, Lee, Seung-Whan, Kim, Young-Hak, Lee, Cheol Whan, Kim, Ho Jin, Kim, Joon Bum, Jung, Sung Ho, Choo, Suk Jung, Chung, Cheol-Hyun, Lee, Jae-Won, Kim, Jae-Joong, Park, Seong-Wook, Park, Seung-Jung

“…Myocardial viability test to guide revascularization remains uncertain in patients with ischemic cardiomyopathy. We evaluated the different impacts of…”
Get full text

Early Surgery Versus Conventional Treatment for Asymptomatic Severe Mitral Regurgitation by Kang, Duk-Hyun, MD, PhD, Park, Sung-Ji, MD, PhD, Sun, Byung Joo, MD, Cho, Eun Jeong, MD, Kim, Dae-Hee, MD, PhD, Yun, Sung-Cheol, PhD, Song, Jong-Min, MD, PhD, Park, Seung Woo, MD, PhD, Chung, Cheol-Hyun, MD, PhD, Song, Jae-Kwan, MD, PhD, Lee, Jae-Won, MD, PhD, Park, Pyo-Won, MD, PhD

“…Objectives This study sought to compare long-term outcomes of early surgery with a conventional treatment strategy in asymptomatic patients with severe mitral…”
Get full text

New brain infarcts on magnetic resonance imaging after coronary artery bypass graft surgery: Lesion patterns, mechanism, and predictors by Nah, Hyun-Wook, Lee, Jae-Won, Chung, Cheol-Hyun, Choo, Suk-Jung, Kwon, Sun U., Kim, Jong S., Warach, Steven, Kang, Dong-Wha

“…Objective New brain infarcts after coronary artery bypass graft (CABG) are markedly more frequent than clinically evident stroke and have been proposed as a…”
Get full text

Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer by Satoh, Taroh, Kang, Yoon-Koo, Chao, Yee, Ryu, Min-Hee, Kato, Ken, Cheol Chung, Hyun, Chen, Jen-Shi, Muro, Kei, Ki Kang, Won, Yeh, Kun-Huei, Yoshikawa, Takaki, Oh, Sang Cheul, Bai, Li-Yuan, Tamura, Takao, Lee, Keun-Wook, Hamamoto, Yasuo, Kim, Jong Gwang, Chin, Keisho, Oh, Do-Youn, Minashi, Keiko, Cho, Jae Yong, Tsuda, Masahiro, Tanimoto, Mitsunobu, Chen, Li-Tzong, Boku, Narikazu

“…Background Data on immune checkpoint inhibitor efficacy in patients with human epidermal growth factor receptor 2-positive (HER2+) advanced…”
Get full text

Anticoagulation During Extracorporeal Membrane Oxygenation; Nafamostat Mesilate Versus Heparin by Lim, Ju Yong, MD, Kim, Joon Bum, MD, Choo, Suk Jung, MD, Chung, Cheol Hyun, MD, Lee, Jae Won, MD, Jung, Sung Ho, MD

“…Background Heparin is the main anticoagulant used during extracorporeal membrane oxygenation (ECMO) support. Nafamostat mesilate, a synthetic serine protease…”
Get full text

New-Onset Diabetes Mellitus After Heart Transplantation　― Incidence, Risk Factors and Impact on Clinical Outcome by Kim, Ho Jin, Jung, Sung-Ho, Kim, Jae-Joong, Yun, Tae-Jin, Kim, Joon Bum, Choo, Suk Jung, Chung, Cheol Hyun, Lee, Jae Won

“…Background:New-onset diabetes mellitus (DM) can occur as a serious complication after heart transplantation, but the comparative data on its clinical impact on…”
Get full text

Long-Term Outcomes After Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents or Coronary Artery Bypass Grafting for Multivessel Coronary Disease by Kim, Tae Oh, Ahn, Jung-Min, Kang, Do-Yoon, Park, Hanbit, Kim, Seon Ok, Lee, Pil Hyung, Lee, Junghoon, Kim, Ju Hyeon, Jeong, Yeong Jin, Yang, Yujin, Hyun, Junho, Kim, Ho Jin, Kim, Joon Bum, Choo, Suk Jung, Chung, Cheol-Hyun, Lee, Jae-Won, Park, Seung-Jung, Park, Duk-Woo

“…More evidence is required with respect to the comparative effectiveness of percutaneous coronary intervention (PCI) with second-generation drug-eluting stents…”
Get full text